PH and Heart Failure –
We are searching for a Cure
The European Pediatric Pulmonary Vascular Disease Network is a non-profit organization that strives to define and develop diagnostic methods and new therapies (pharmacotherapy, critical care, VAD/ECMO, cahter/surgical interventions, bilateral lung transplantation) in all forms of pediatric hypertensive vascular disease (PHVD):
The forms of PHVD include pulmonary arterial hypertension (e.g., idiopathic PAH, hereditary PAH, and pulmonary hypertension (PH) associated with congenital heart disease (PH-CHD)), PH associated with chronic lung disease (PH-nCLD/bronchopulmonary dysplasia), persistent pulmonary hypertension of the newborn (PPHN), pulmonary venoocclusive disease (PVOD), pulmonary capillary hemangiomatosis, among others.
Moreover, the network adresses the detrimental cardiac dysfunction and heart failure associated with PH, in particular, the RV – pulmonary artery (PA) unit, right ventricular failure, RV – LV interaction and LV compression, right (RA) and left atrial (LA) hypertension.